Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02687438 · ClinicalTrials.gov registry record · NA
The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery
A NA study of Chronic Sinusitis, sponsored by ENT and Allergy Associates.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 4
- Study locations
NCT02687438: Completed NA study of Chronic Sinusitis, sponsored by ENT and Allergy Associates.
NCT02687438 is a NA study of Chronic Sinusitis that has completed, run by ENT and Allergy Associates. The registered enrollment target is 20 participants, below the 194-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02687438, a NA study of Chronic Sinusitis, has completed, sponsored by ENT and Allergy Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 4
- Study locations
Study Summary
Report on the technical feasibility and outcomes of in-office placement of PROPEL or PROPEL mini implants immediately following ethmoid sinus surgery
Primary Outcome
nasal obstruction/congestion scored by patients
Conditions Studied
Interventions
- DEVICE Steroid-releasing sinus implant
- OTHER Post-op standard of care
Study Locations (4)
New York
- ENT and Allergy Associates, LLP - Lake Success
- ENT and Allergy Associates, LLP - New York
- ENT and Allergy Associates, LLP - Port Jefferson
- ENT and Allergy Associates, LLP - White Plains
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-02 |
| Phase | NA |
What the finished NCT02687438 record still lists
NCT02687438 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 194-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Chronic Sinusitis appearing as the primary indexed condition, and to 2 interventions - of which Steroid-releasing sinus implant is the first listed.
NCT02687438 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02687438 about?
NCT02687438 is a clinical study titled "The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery". Report on the technical feasibility and outcomes of in-office placement of PROPEL or PROPEL mini implants immediately following ethmoid sinus surgery
What is the current status of trial NCT02687438?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-12. Estimated completion is 2016-02.
What conditions does trial NCT02687438 study?
This clinical trial studies the following conditions: Chronic Sinusitis.
What interventions are being tested in trial NCT02687438?
The interventions under investigation include: Steroid-releasing sinus implant (DEVICE), Post-op standard of care (OTHER).
Who is sponsoring clinical trial NCT02687438?
This trial is sponsored by ENT and Allergy Associates, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02687438 being conducted?
This trial has 4 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Sinusitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02687438's enrollment target sits among peer trials
20 10th of 9 the lowest of 9 other Chronic Sinusitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Sinusitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Evaluation of Maxillary Antrostomy Versus Ostial Dilation Efficacy Through Long-Term Follow-Up
COMPLETED · NA
-
Intraoperative and Post-operative Analgesic Effect of IV Acetaminophen for Sinus Surgery
COMPLETED · NA
-
Safety and Efficacy of Balloon Sinuplasty in Pediatric Sinusitis
COMPLETED · NA
-
XprESS Maxillary Balloon Dilation Study
COMPLETED · NA
-
Genetic Factors in Chronic Sinusitis
ACTIVE NOT RECRUITING
-
Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia